Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Warning letter issued July 11, 2024 · Lianyungang, China

Inspection: Jan 8 – Jan 16, 2024
Pages: 6
FEI number: 3007373503

In short: On July 11, 2024, FDA sent a warning letter to Jiangsu Hengrui Pharmaceuticals Co., Ltd. in Lianyungang, Jiangsu (FEI 3007373503).

Inside this warning letter

The full warning letter

Every page of the warning letter, exactly as written.

Get the full warning letter

This inspection in context

The firm

Jiangsu Hengrui Pharmaceuticals Co., Ltd. history

All 2 documents on file for this site, in date order, with what was cited at each inspection.

Complete the picture

483
Form 483 from this inspectionJan 16, 2024$99

Jiangsu Hengrui Pharmaceuticals Co., Ltd. site file

All 2 documents for this site in one go: $198.

See the site history

Questions about this warning letter

When was Jiangsu Hengrui Pharmaceuticals Co., Ltd. inspected by FDA?

The inspection ran Jan 8 – Jan 16, 2024, and the Warning letter is dated July 11, 2024.

How do I get the full Warning letter for Jiangsu Hengrui Pharmaceuticals Co., Ltd.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.